RATIONALE: Flagellin which is abundant in gram-negative bacteria including pseudomonas is reported to be related with development of asthma. However, its effect on airway epithelial cells regarding asthma pathogenesis is not elucidated yet. We investigated the effect of flagellin on the production of cytokines, chemokines and metalloproteinase related with airway inflammation and remodeling in the primary human epithelial cells. METHODS: Primary human bronchial epithelial cells were grown and differentiated in air-liquid interface culture for 14-16 days. The cells were treated with flagellin in vitro at 10 and 100ng/ml for 3, 24, and 48hours. The conditioned media and cells were harvested to measure cytokines, chemokines and metalloproteinase related with asthma and their mRNA expressions by ELISA or western blot and quantitative PCR, respectively. RNA-sequencing was performed to screen the up-regulated and downregulated transcriptomes by flagellin. RESULTS: Flagellin upregulated mRNA expressions of GM-CSF at 3hrs of treatment and increased GM-CSF secretion significantly at 24hr in conditioned media. Flagellin enhanced mRNA expressions and secretions of CCL5, CXCL10, CXCL11 chemokines, which were detected in the RNA-sequencing. In addition, mRNA expressions and protein productions of MMP9 and MMP13 were also enhanced by flagellin. TGF-b1 and TGFb2 augmented the mRNA expressions of GM-CSF, MMP9 and MMP13 induced by flagellin. CONCLUSIONS: Flagellin is an inducer of cytokines, chemokines and metalloproteinase contributing to airway inflammation and remodeling in bronchial epithelial cells. Further studies are needed to clarify their interaction with other inflammatory and structural cells and clinical implications in terms of asthma. National Institute of Environmental Health Sciences, Research Triangle Park, NC. RATIONALE: Blomia tropicalis is a well-known asthma inducer house dust mite: however, few allergens from this source have been fully characterized. We aimed to evaluate if Blo t 8 has the ability to induce airway inflammation. METHODS: Blo t 8 was obtained as a tag-free recombinant protein in BL21 (DE3). BALB/c mice were sensitized i.p. with alum-adsorbed Blo t 8, ovalbumin (OVA) or PBS and challenged intranasal with the same allergen. Airway inflammation was evaluated by lung histology (hematoxilin/eosin and PAS) and cell count in bronchoalveolar lavage (BAL) by flow cytometry. Immunoglobulin isotypes were measured in serum by ELISA. The allergenic activity was also evaluated by passive cutaneous anaphylaxis (PCA). RESULTS: Blo t 8 and OVA induced similar total IgE levels but the strength of specific-IgE and -IgG1 production was significantly higher in the former. Blo t 8 sensitization and challenge did not induce bronchial inflammation or mucus production. In contrast, OVA sensitized mice showed goblet-cell hyperplasia and an eosinophil-rich infiltrate. In contrast to OVA, Blo t 8 significantly raised specific-IgG2a production. In regard to the PCA test, the allergenic activity of Blo t 8 was intermediate, being higher for OVA and negative for PBS. CONCLUSIONS: Blo t 8 induced a strong IgE response, but failed to induce airway inflammation. Our results suggest that the simultaneous induction of allergen-specific IgG2a could have protective effects on pathogenic allergen-elicited IgE responses.
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